Vista Pharmaceutical

VISTAPH
Price
-- --
 
Nano Cap
₹46 Cr.
Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmaceutical, medical, and veterinary preparations including generic drugs in tablet, capsule, and liquid form… More
Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmaceutical, medical, and veterinary preparations including generic drugs in tablet, capsule, and liquid forms. The company serves both over the counter and prescription markets, with a focus on various therapeutic categories. Vista Pharmaceuticals aims to produce high-quality products and initially targeted the United States market, with plans for global expansion. Less
Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmaceutic… More
Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmaceutical, medical, and veterinary preparations including generic drugs in tablet, capsule, and liquid forms. The company serves both over the counter and prescription markets, with a focus on various therapeutic categories. Vista Pharmaceuticals aims to produce high-quality products and initially targeted the United States market, with plans for global expansion. Less
Low
5.71
52W Range
High
11.69
PE
--
Sector PE
30.34
P/B
1.26
Div.Yield
--
ROE
--
EBIDTA
--
ROCE
-9.93
EPS
-0.95
WhatsApp

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

VISTAPH
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    VISTAPH
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
    Feb 03, 2026
    Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
    Feb 19, 2025
    Vista Pharma Gets License To Make Sulfamethoxazole And Trimethoprim Tablets For Export
    Nov 14, 2024
    Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
    Sep 06, 2023
    Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
    Sep 01, 2023
    Events:
    Announcement Date
    May 29, 2026
    Announcement Date
    Feb 13, 2026
    Announcement Date
    Nov 13, 2025
    Announcement Date
    Sep 08, 2025
    Announcement Date
    Aug 13, 2025
    Announcement Date
    May 30, 2025
    Announcement Date
    Feb 12, 2025
    Announcement Date
    Nov 13, 2024
    Announcement Date
    Sep 08, 2024
    Announcement Date
    Aug 13, 2024
    Announcement Date
    Feb 10, 2024
    Announcement Date
    Nov 10, 2023
    Announcement Date
    Sep 07, 2023
    Announcement Date
    Aug 12, 2023
    Announcement Date
    May 30, 2023
    Announcement Date
    Feb 13, 2023
    Announcement Date
    Nov 14, 2022
    Announcement Date
    Sep 07, 2022
    Announcement Date
    Aug 13, 2022
    Announcement Date
    May 30, 2022
    Announcement Date
    Feb 14, 2022
    Announcement Date
    Nov 13, 2021
    Announcement Date
    Aug 14, 2021
    Announcement Date
    Jun 30, 2021
    Announcement Date
    Feb 12, 2021
    Announcement Date
    Nov 12, 2020
    Announcement Date
    Sep 14, 2020
    Announcement Date
    Jul 20, 2020
    Announcement Date
    Jun 30, 2020
    Announcement Date
    Feb 13, 2020

    More Nano Cap Ideas

    See similar 'Nano' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List